Site icon Edmonton Herald

Biden administration moves ahead with Medicare drug price negotiations amid industry lawsuits

Undeterred by a growing number of lawsuits, the Biden administration on Friday released revised guidance for Medicare’s new drug price negotiation program.

Exit mobile version